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Abstract
Background: Total knee and total hip joint arthroplasty are two frequently preformed surgeries,
with 5.2 million total knee arthroplasties performed the United States between the year 2000 and
2010 (Williams et al., 2015). Opioids are widely used to manage pain for patients undergoing
total joint arthroplasty. However, use of opioids is associated with undesirable adverse effects,
such as nausea and respiratory depression, (Johnson et al., 2011). In postoperative patients
following total joint replacement, 75 % of the patients complain of inadequately controlled
moderate to severe pain (De Luca et al., 2018). Increased use and overprescribing increase
tolerance to opioids and can result in poorly controlled acute post-operative pain leading to
chronic pain, impaired mobility, and negative long-term outcomes.
Aim: Examine if long term opioid pain management has an impact on early postoperative
mobilization, long-term dependence, and overuse of opioid medications after total joint
arthroplasty.
Proposal: Increased consumption and long-term use of opioids preoperatively can lead to
unmanaged postoperative pain. Use of multimodal analgesia and preemptive analgesia can lead
to improved outcomes for patients who are undergoing total joint arthroplasty of the knee and
hip. The proposed study aims to examine if use of such modalities can have improved long terms
outcomes in patients undergoing total joint arthroplasty.
Methodology: A review of full text literature was performed on March 11, 2021 using PubMed
and CINHAL and Google Scholar through the Dominican University Databases. The keyword
terms used were “pain management,” “pain control,” “total knee arthroplasty,” “total hip
arthroplasty,” and “total joint arthroplasty.” The search generated 180 full text articles of which
four were used for this research paper.
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Recruitment strategy: Inpatient and outpatient post-operative patients undergoing total knee
arthroplasty and total hip arthroplasty with moderate to severe uncontrolled pain.
Measurements: Using the 36-Item Short Form Health Survey to review impact of health on the
participants everyday life. Quality and intensity of experienced pain the McGill Pain
Questionnaire will be used. Current Opioid Misuse Measure (COMM) assessment tool will be
used to evaluate aberrant medication related behavior, while the opioid consumption and the
corresponding daily morphine milligram equivalent amount (MME) will be evaluated at the
preoperative period and in the immediate postoperative.
Analysis: Participants general demographics will be recorded and means, and standard
deviations will be calculated. Proportions will be determined on race, education, and income. A
t-test will be used to compare the means of two groups, those who are consuming preoperative
opioids and those who are not, to determine whether there is statistical evidence associated with
population means and has are significantly different and influences the population of interest.
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Increased Use of Opioids Perioperatively Leads to Unmanaged Postoperative Pain
Effective postoperative pain management is an essential part of the care for postoperative recovery in surgical patients after total knee and hip joint arthroplasty. Adverse
outcomes, such as chronic pain, impaired function, prolonged opioid use, and poor quality of life
can lead to mortality and morbidity that can result from inadequate pain control (Gan, 2017). The
surgery may result in the suppression of the immune system, due to anesthetic drugs, and is often
in proportion to the invasiveness of the surgery performed (Wang et al., 2019). The factors that
lead to increased risk is anesthesia duration, number and size of incision, along with
complications during surgery and any underlying medical problems (Zambouri, 2007). Effective
postoperative pain control and management can lead to improved patient comfort, earlier
mobilization and reduced incidence and risk of deep venous thrombosis by allowing increased
mobility, and lead to faster recovery without development of chronic pain (Gan, 2017).
However, increased use of opioids and overprescribing can lead to increased tolerance and result
in unmanaged acute pain (Hah et al., 2017). When pain is poorly managed in the acute
postoperative period, patients can develop chronic pain and have impaired mobility, prolonged
recovery, increased risk for complications – such a thrombosis and poor mobility, resulting in
poor quality of life.
In order to achieve optimal postoperative pain management, lack of knowledge,
reluctance, and false concerns about addiction must be recognized (Al-Mahrezi, 2017).
Furthermore, the presence and intensity of acute pain during or after surgery is predictive of the
development of chronic pain and can be a source of patient dissatisfaction (Al-Mahrezi, 2017).
Prescribing methods for peri-operative analgesic are varied and can lead to inadequate pain
control. Improper management of post-surgical pain is associated with delay in healing, increase
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in suffering and complication rates, anxiety and sleep-disturbance, and a decrease in quality-oflife post-surgery (Baratta et al., 2014). A study, which included 250 eligible participants,
showed that 82% of patients continue to experience acute pain after surgery, with the majority
experiencing moderate-to-severe pain (Baratta et al., 2014). Barriers to acute postoperative pain
management are related to lack of communication with the patient and fear of opioids with the
possibility of addiction post-operatively. Such barriers lead to decreased satisfaction of pain
management and furthermore, poor pain control that is associated with an increase in
psychological distress, decreased social activities, prolonged rehabilitation, and chronic pain
(Sinatra et al., 2002). Often patients lack understanding of the complexity of pain and the need
for multimodal pain management (Barrata et al., 2014). Nursing and physician barriers to
adequate post-operative pain management are related to inadequate knowledge of pain
management regimens, negative attitudes related to opioid use, and poor understanding of
complexity of pain and associated side effects (Barrata et al., 2014).
Aim
Does increased pre-operative opioid use and overprescribing lead to poor post-surgical
outcomes in patients undergoing total knee and total hip arthroplasty?
Literature Review
The full text research articles were found using databases through the Dominican
University of California library and included CINAHL, PubMed, and Google Scholar. The
search terms used were “pain management,” “pain control,” “total knee arthroplasty,” “total hip
arthroplasty,” “total joint arthroplasty,” and “preoperative opioid use.” The search generated 180
full text articles of which four were used for this research paper and are included in this literature
review.
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The review of relevant literature has been divided into two categories, articles discussing
the use of multimodal analgesia and its effect on opioid consumption and articles that
demonstrate how increased use of opioids and overprescribing negatively impacts patient
recovery and patient satisfaction after total joint arthroplasty of the knee and hip.
Use of Multimodal Analgesia and its Effect on Opioid Consumption
Thomazeau, et al. (2015) sought to examine how post-operative pain was reflected when
patients were not exercised with physical therapy. The study of 109 patients undergoing total
knee arthroplasty recorded patient characteristics, preoperative pain intensity, anxiety and
depression levels, sensitivity and pain thresholds in response to an electrical stimulus. The goal
of the study was aimed at improving consequences related to “nociceptive stimulation postoperatively” and prevent adverse consequences of increased opioid consumption. The study
found that opioid requirements vary significantly and are dependent on duration of pain
experienced, anxiety levels and are influenced by both pharmacokinetic and pharmacodynamic
factors (Thomazeau et al., 2015). Of the 109 patients observed in the study, more than 50 percent
suffered from knee pain for longer than five years. Further, the study showed that the mean postoperative pain intensity for patients receiving opioids preoperatively was higher than in those
receiving pregabalin and celecoxib post-operatively (4.0 ± 2.0 vs. 3.0 ± (p<0.001) (Thomazeau et
al., 2015). Additionally, the mean postoperative requirement for opioids was higher for patients
who were physically inactive at the time of surgery and in those who consumed opioids for pain
management prior to surgery (Thomazeau et al., 2015). The study found that anxiety in patients
preoperatively would negatively impact pain control post-operatively (Thomazeau et al., 2015).
This suggests that anxiety is predictive for “post-operative pain intensity” and a decrease
in use of opioids and multimodal analgesia must be considered when treating patients
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undergoing total knee arthroplasty; however, the long-term use of opioids and potential tolerance
which could prove problematic for effective pain management postoperatively was not
sufficiently addressed in the study. The study did determine that the use of COX-2-selective
inhibitors and pregabalin significantly reduced pain intensity and requirement for opioids in the
post-operative period; however, due to a low percentage (3 percent) of patients who expressed
dissatisfaction with post-operative pain management the study demonstrated that the use of
multimodal analgesia in addition to opioids is significantly more effective in treatment of postoperative pain after total knee arthroplasty (Thomazeau et al., 2015).
Jing-wen et al., 2019), determined that 60 percent of the total knee arthroplasty patients
experience severe postoperative pain, while 30 percent of postoperative total knee arthroplasty
patients experience moderate pain. The study aimed to examine the benefit of multimodal
anesthesia and improved postoperative recovery (Jing-wen et al., 2019). Controlling moderate to
severe pain postoperatively in total knee arthroplasty patients is imperative in order to promote
ambulation and range of motion to decrease prolonged immobility and subsequent
complications. The study found that optimally a combination of preemptive analgesia,
cyclooxygenase-2 inhibitors, nerve blocks and adequate post-operative analgesia in addition to
opioids should be considered in order to relieve severe post-operative pain and decrease longterm dependence on opioids (Jing-wen et al., 2019). Furthermore, the study discovered that
mechanisms related to post-operative pain are related to both peripheral and central mechanisms
and the use of monotherapy is suboptimal to adequate pain management thus use of multimodal
analgesia not only reduces the pain both preoperatively and postoperatively, but decreases opioid
dependence and decreases the risk of associated adverse effects resulting in improved patient
satisfaction (Jing-wen et al., 2019). Additionally, Jing-wen et al., (2019) discovered that use of
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preemptive analgesia reduces the risk of hypersensitivity and aids in pain reeducation
postoperatively. Most importantly, chronic use of opioids in the pre-operative period results in
tolerance and leads to decreased pain relief postoperatively and subsequently an increased
requirement for opioids (Jing-wen et al., 2019). The study also found that the use of local
infiltration anesthesia with liposomal bupivacaine decreased pain post-operatively (19.7 mg vs
84.9 mg, P = 0.0048) reduced opioid consumption in the post-op period and prolonged time to
rescue opioids without adverse effects (Jing-wen et al., 2019).
These studies demonstrate that long-term opioid use increased the potential for tolerance
which can lead to unmanaged preoperative and postoperative pain in patients that are undergoing
total joint arthroplasty of the hip or knee. Using preemptive analgesia can help reduce the risk of
increased opioid use in patients scheduled to undergo total joint arthroplasty. Additionally,
utilization if cox-2 inhibitors can reduce the use of opioids. Utilization if multimodal analgesia
postoperatively can aid in better postoperative pain management that can reduce the risk of
uncontrolled pain and result in better patient outcomes postoperatively.
Increased Use of Opioids and Overprescribing Negatively Affects Patient Recovery and
Satisfaction Post-Operatively
Ruddell et al., aimed to examine if larger opioid prescriptions after total joint arthroplasty
are associated with an increased risk of dependence. The study found that total hip arthroplasty
patients had higher opioid tolerance than those who underwent total knee arthroplasty (25.3 %
vs. 14.6 %, p = 0.004); however, the total knee arthroplasty patients showed a prolonged opioid
use in the post-operative period (37.9% vs 17.2, p < 0.001). The initial outpatient dose prescribed
postoperatively was related to prolonged use of opioids (OR 1.286, 95% CI, 1.002 to 1.654; p
=0.049) for a 1 standard deviation increase of 332.0 in the initial MMEs for total hip arthroplasty
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patients, and for the total knee arthroplasty patient group (OR 1.248, 95% CI, 1.001 to 1.558; p =
0.049) for a one standard deviation increase of 292.5 in initial MMEs (Ruddell et al., 2021).
The study also revealed increased odds of prolonged opioid use associated with quantity
of opioids administered during the inpatient period (OR 1.523, 95% CI, 1.183 to 1.961; p =
0.001) for one standard deviation increase of 105.9 inpatient MMEs for total hip arthroplasty and
(OR 1.466, 95% CI, 1.165 to 1.845; p = 0.001) for a 1 standard deviation increase of 96.3
inpatient MMEs for TKA (Ruddell et al., 2021). It was also discovered that there is a dose
dependent correlation between the initial prescription of opioids and the total opioid quantity
filled by patients in the prolonged and chronic postoperative period (Ruddell et al., 2021).
Schlosser et al., (2020) in the retrospective metanalyses aimed to examine the
relationship between opioid use and post-operative length of stay and the readmission rates for
patients who have undergone hip and knee arthroplasty. Furthermore, the aim was to examine the
enhanced surgical recovery protocols that include multimodal pain management as a key process
(Schlosser et al., 2020). The study found that the patients receiving treatment with lower doses of
opioids had shorter median length of stay (p < 0.001) and that this earlier discharge had no
negative impact on readmission rates. Patients that were discharged on day one and received a
lower (MME) per day than those who were not discharged (32.5 [IQR: 19.0–50.0] versus 45.0
[26.7–71.2], p < 0.001) (Schlosser et al., 2020). The study found that patients discharged on day
two had similar results (43.5 [26.0–67.0] versus 48.0 [27.5–77.0], p < 0.001), but not for those
discharged on day three (Schlosser et al., 2020). The number of opioids used following joint
arthroplasty is associated with discharge date and with lower amounts of opioid used and are
linked to the probability of earlier discharge for both days one and two (Schlosser et al., 2020).
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According to the study, the amount of opioid dose per day is found to be the strongest predictor
of earlier discharge date (Schlosser et al., 2020).
In conclusion, the study discovered that the probability of an earlier discharge following
joint arthroplasty and a decreased chance of readmission is associated with use of lower amounts
of opioids following surgery (Schlosser et al., 2020).
Larger doses of opioid and prolonged use have been shown to be associated with
increased pain and tolerance postoperatively in patients that are undergoing total joint
arthroplasty of the hip or the knee. Additionally, prolonged use of opioids is associated with
quantity of opioids prescribed and administered during the hospitalization period. Patients who
consumed lower doses have been found to be discharge home sooner than those who consume
larger doses. Increased doses were not only found to be associated with longer hospital
admissions, but also higher readmission rates.
Theoretical Framework
The aim of the proposed study is to examine if opioid pain management has an impact on
early postoperative mobilization, long-term dependence and overuse of narcotic medications
after total joint arthroplasty. To address this gap the biopsychosocial model is used to address the
underlying pain perception. This model allows for optimal foundation that is comprehensive and
tailored for specific patient needs. Chronic pain is a debilitating and widespread condition that
affects millions of individuals worldwide. In 2015, more than 25 million Americans reported
experiencing chronic and consistent pain daily (Nahin, 2015). The differences in how patients
experience and communicate the experience can result in varying treatment due to physician
interpretation of the patient experience report (Beavers et al., 2016). The difficulties in treatment
and assessment of pain has led to overprescribing of opioids that does not result in treatment of
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the underlying causes of pain. Opioids, which are highly addictive and present associated
negative outcomes such as misuse and overuse.
The experience of chronic pain encompasses unpleasant experiences, both physical and
emotional, associated with actual or potential damage. In acute conditions, the pain is resolved
when the problem is addressed and treated; however, chronic pain requires continuous
monitoring and treatment with multiple approaches (Beavers, 2015). The biopsychosocial model
focuses on treating the individual as a whole and integrates both the mind and the body and
acknowledges the biological, psychological, and social components that are associated with the
pain experience. It also places an emphasis on illness and how one lives with or responds to the
condition and related symptoms (Beavers et al., 2016). Figure 1 gives a brief overview of the
biopsychosocial mode (Liebson et al., 2020).
Figure 1: The Biopsychosocial Model
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This theory posits that pain is not simply a neuropsychological phenomenon, but rather
depends on both social and psychological factors such as culture, family, nociceptive stimuli and
environment which influence pain perception leading to an impact on an individual’s response to
pain and associated behaviors (Dekkers et al., 2018). Johnson et al., (2013), defines acute pain
management as a complex process involving activation of nociceptors, chemical mediators and
inflammation (Johnson et al., 2013). The study further explains that pain medication is used to
target each of the key elements within the pain pathway and eliminate or reduce the sensation of
pain (Johnson et al., 2013). The authors explain that pain management should begin prior to the
trauma or injury of the tissues, when possible, and continue throughout the perioperative period
in order to appropriately manage pain and improve both clinical outcomes and satisfaction for
the patient (Johnson et al., 2013). However, some research suggests that early use of opioids for
pain management leads to impaired post-operative function and long-term pain (Goplen at al.,
2019).
Design
Methodology
Prospective cohort study to examine long term opioid use preoperatively and associated
negative effects of pain control in the postoperative period of patients undergoing total joint
replacement of the hip or knee. Using quantitative data, the study will examine self-reported
preoperative opioid consumption, actual post-operative opioid consumption, and self-reported
pain. Patient-reported outcome measures will be assessed at in the immediate post-operative
period and at three, six, and twelve months postoperatively. The patient pain experience will also
be examined.
Site and Sample
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I will target a sample of 500 post-operative total hip and knee joint replacement patients,
ten participants per variable (Independent Variable, Dependent Variable, covariates) per
stratified group (those that use and those that do not use pre-operative opioids) by using the
California Joint Replacement Registry (The Joint Commission, 2020). Patients will be given a
survey during the immediate postoperative period to examine preoperative opioid consumption
and the corresponding daily morphine equivalent amount and postoperatively at three months,
six months, and twelve months.
Inclusion Criteria
The inclusion criteria for this study will be patients who scheduled to undergo primary
total hip or total knee arthroplasty. Additionally, patients who are prescribed preoperative
opioids for pain management of end-stage osteoarthritis and compared with those that were not
prescribed opioids preoperatively for end-stage osteoarthritis will be included. Patients who are
scheduled for a total joint replacement of the hip or of the knee due to end-stage osteoarthritis
will also be included in this study. And finally, patients who are between the ages of 55 and 85
years old and scheduled for total joint arthroplasty of the knee or hip for treatment of end-stage
osteoarthritis will fall in the inclusion criteria.
Exclusion Criteria:
The exclusion criteria for this study will include Rheumatoid Arthritis, which has an
increased risk of complications. These include increased risk for infection due to compromise to
the systemic immune system, impaired wound healing resulting from impaired skin integrity or
frail skin, and peroneal nerve injury caused by overcorrection of severely deformed knees.
Postoperative stiffness is more common due to generalized muscular weakness and disability
(Goodman, 2014). Additionally, patient scheduled for Revision total joint arthroplasty of the hip
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or the knee as such procedures are associated with higher rate of infection and complications
(Badarudeen et al., 2017). Patients with significant cognitive impairment such that they cannot
self-report or consent and those with significant clinical anxiety disorder will also be excluded
from this study.
Protocol
The access to the total joint registry will be obtained through the Joint Commission and
American Academy of Orthopedic Surgeons. A chart review of patient clinical information will
be performed. Potential subjects will be contacted, and an invitation will be sent with a response
card. Thirty days will be allowed for response and follow-up with a second invitation with a
response card will be sent if a response has not been received. After a third invitation, 30 days
will be permitted for a response. If no response, the potential subject will be removed from list.
The subject will be screened the for clinical appropriateness for participation in study. All
subjects must meet inclusion. Any subjects that fall within the exclusion criteria will be removed.
Subjects who meet the inclusion criteria will be enrolled and the consent will be reviewed with
the subjects. We will ensure that subjects understand that participation is voluntary. The
measurement survey tools will be administered to the subjects, data will be obtained, and
recorded. Recruitment is 500 participants, and the study is estimated to complete enrollment
within six months from the initiation. If enrollment of 500 participants is not met the study will
adjust participation of subjects accordingly.
What will you do to preserve privacy?
Participants will sign informed consent and can end participation at any point during the
study. Records will be secured using secure password protected files. Only members of the
research team will be permitted access to the passwords. Encryption will be used when
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information is sent and communicated over the internet and through email. Participants will be
assigned alpha numeric codes and names will not be used. Physical files and information will be
kept in locked cabinets to which only members of the research team are granted access.
Measurement/Tools
Demographic survey will be administered for age, gender, education, income, race and
ethnicity, history of employment, and chronic conditions (such as diabetes, heart conditions, or
lung disease). The 36-Item Short Form Health Survey (SF-36), developed by the Boston Health
Research Institute (1991), will be used to assess impact of health and quality of participants
lives. The SF-36 questionnaire Cronbach alpha exceeds 0.70 for internal consistency and
reliability, a P-value of < 0.05, and correlation coefficient (r > 0.50), meeting the recommended
level (Zhang, 2012).
The McGill Pain Questionnaire (1975) (r: 0.43-0.88, P<0.001) will be used to assess pain
severity, quality, and intensity of experienced pain which produces (K=0.97) validity statistic,
Cronbach's alpha of 0.88 and 0.90 and interclass correlation class coefficient 0.73 to 0.90
(Kachooei, 2015). Using the Current Opioid Misuse Measure (COMM), a 17-item questionnaire
designed to identify patients who may be misusing their prescription opioids. The questionnaire
will be designed to identify the likelihood of aberrant drug-related behaviors with higher scores
representing increased risk (PLR, 2.77 [95% CI, 2.06 to 3.72), while lower scores on the COMM
are consistent with decreased likelihood of abuse (NLR, 0.35, 95% CI, 0.24 to 0.52]) (Chou et
al., 2009). The quantity of daily opioids used will be assessed by converting the daily dosage of
opioids consumed to Milligram Morphine Equivalent (MME), which is the value that will be
assigned to opioids to represent the relative potency. The outcome of interest is post-operative
pain, which will be measured using The McGill Pain questionnaire. The independent (exposure)
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variable is the use of pre-operative opioids, measured using Milligram Morphine Equivalent.
Covariates of interest examined will be history of smoking, use of daily simple analgesics
(NSAIDs), body mass index (BMI) and duration of wait for surgery. Smoking leads to greater
loss of cartilage and can result in more pain (Amin, 2007). High BMI poses a significant risk for
osteoarthritis (Zheng, 2015). All participants will respond to a demographic survey that will
determine age, meeting the requirement of research study, gender, income, race, and ethnicity.
Pre-operative opioid use (independent variable) will be determined by converting current
cumulative intake of any medication in the opioid class over a twenty-four-hour period and
converting to MME, which is an equivalency factor to measure a dose of morphine that is
equivalent to the ordered opioid, (95% confidence interval, -13.96 – 1 4.56) (Heins, 2020). The
post-operative analgesia and type of analgesia (dependent variable) will be recorded by
reviewing the electronic medication administration record and converting any medication
administered in the opioid class to MME.
Analysis
A correlational design will be used to determine a relationship between use of opioids
preoperatively and determine the possible negative outcome on long-term opioid dependence and
chronic pain. Additionally, if use of multimodal analgesia and short-term opioid use has a
positive outcome on postoperative patient recovery after total joint arthroplasty of the hip and
knee in relation to early mobility, decreased incidence of venous thromboembolism, decreased
pain and patient postoperative satisfaction and quality of life after surgery.
Means and standard deviations will be calculated on age and years of educations.
Proportions will be determined on race, education, and income. A t-test will be used to compare
the means of two groups, those who are consuming preoperative opioids and those who are not,
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in order to determine whether there is statistical evidence associated with population means are
significantly different and has an effect on the population of interest. The t-test will allow to
make comparison between the two independent groups, those that are consuming preoperative
opioids and those who are not allowing for determination to be made regarding which variable
levels have the most significant impact on the association (Fain, 2017). A p-value of less than
0.05 will be considered statistically significant. A t-value of 0.95 for a confidence interval will be
used (Fain, 2017).
A demographic survey will be administered for age (years) where a mean will be
determined, gender (female; male; transgender female; transgender male; prefer not to answer),
education where a mean years of schooling will be determined (12th grade or less; graduated high
school or equivalent; some college, no degree; associate degree; bachelor’s degree; post-graduate
degree), median income ($20,000 or less; $20,000 to $34,999; $35,000 to $49,999; $50,000 to
$74,999; $75,000 to $99,999; $100,000 and over), race and ethnicity (Hispanic/Latino;
Hawaiian/Pacific Islander; White; Black/African-American; Asian; Native American/Alaska
Native, and employment (employed full-time; employed part-time; seeking opportunities;
retired; prefer not to say).
The 36-Item Short Form Health Survey (SF-36). The SF-36 questionnaire Cronbach
alpha exceeds 0.70 for internal consistency and reliability, a P-value of < 0.05, and correlation
coefficient (r > 0.50) (Zhang, 2012).
Pre-operative opioid use (independent variable) will be determined by converting current
cumulative intake of any medication in the opioid class over a twenty-four-hour period and
converting the amount to MMEs (95% confidence interval, -13.96 – 1 4.56) (Heins, 2020).
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The post-operative analgesia (dependent variable) and type of analgesia will be recorded
by reviewing the electronic medication administration record and converting any medication
administered in the opioid class to MMEs 95% confidence interval, -13.96 – 1 4.56) (Heins,
2020).
Chronic conditions, such as diabetes, heart conditions, or lung disease will be used as
covariates to improve the accuracy of the model and may significantly affect the final analysis
results as the participants of different demographics and populations may have different
outcomes.
Pain intensity will be measured using the McGill Pain Questionnaire (1975) (r: 0.430.88, P<0.001) which will be used to assess pain intensity of (K=0.97) validity statistic,
Cronbach's alpha of 0.88 and 0.90 and interclass correlation class coefficient 0.73 to 0.90
(Kachooei, 2015).
Pain quality will be measured using the McGill Pain Questionnaire (1975) (r: 0.430.88, P<0.001) to assess pain quality of experienced pain which produces (K=0.97) validity
statistic, Cronbach's alpha of 0.88 and 0.90 and interclass correlation class coefficient 0.73 to
0.90 (Kachooei, 2015).
The (COMM) will be used to identify opioid prescription misuse behavior. The
likelihood of aberrant drug-related behaviors with higher scores representing increased risk
(PLR, 2.77 [95% CI, 2.06 to 3.72), while lower scores on the COMM are consistent with
decreased likelihood of abuse (NLR, 0.35 [95% CI, 0.24 to 0.52]) (Chou et al., 2009).
A correlational design will be used to determine a relationship between use of opioids
preoperatively and determine the possible negative outcome on long-term opioid dependence and
chronic pain. Additionally, if use of multimodal analgesia and short-term opioid use has a
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positive outcome on postoperative patient recovery after total joint arthroplasty of the hip and
knee in relation to early mobility, decreased incidence of venous thromboembolism, decreased
pain and patient postoperative satisfaction and quality of life after surgery.
Human subject protection
Application to the IRB to ensure that the rights and welfare of study subjects are
protected. Ethical considerations will need to be made to ensure patient safety in the
postoperative period and to keep patient information confidential and anonymous. Using
assigned laptops that only permits access to the researchers and ensure password security is
enabled. No data collection will occur until the study and research is approved by the Dominican
Internal Review Board. The participants will be informed that they may cease participation at
any time and that submission of the survey will constitute informed consent.
Limitations
This study has limitations, including the prospective design which will require a longterm follow-up with study subjects. Additional limitations are related to potential for insufficient
data relating to patient’s actual consumption of opioids prescribed in the preoperative period,
inability to evaluate all protocols and policies regarding opioid prescribing, and largely varied
protocols and policies related to preoperative counseling and education for patients suffering
from end-stage osteoarthritis and total joint arthroplasty of the hip and knee.
Conclusion
With total knee and total hip arthroplasty being the two of the most common surgeries
performed for patients suffering from end-stage osteoarthritis, the perioperative management of
patient’s pain is extremely important in order to improve rehabilitation, increase patient mobility,
and improve both patient satisfaction and postoperative outcomes. Increased pre-operative opioid
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use and overprescribing could potentially lead to poor post-surgical outcomes in patients
undergoing total knee and total hip arthroplasty.
Despite the use of multimodal analgesia, opioids will continue to be required for
management of postoperative pain in patients who have undergone total joint arthroplasty of the
hip or the knee. When planning treatment and surgical intervention for patients with end-stage
osteoarthritis, the pain management perioperatively must be considered for each patient and
tailored to preoperative and postoperative needs individually. The length of symptoms
experienced preoperatively, and advancement of condition will play a role in treatment for each
patient’s pain management regimen.
Use of different analgesia regimens can aid in decreased use of opioids preoperatively
and potentially reduce the risk of opioid related adverse effects while improving post-operative
satisfaction and recovery for patients. The proposed study will aid in evaluating perioperative
opioid use in treatment of pain associated with end stage osteoarthritis. Additionally, it will
evaluate use of multimodal analgesia, such as cox-2 inhibitors in addition to opioid prescribing
patterns perioperatively to aid in pain management associated with end-stage osteoarthritis and
improve postoperative outcomes and satisfaction for patients undergoing total joint arthroplasty
of the hip and knee.
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